from Reuters: Health News https://ift.tt/2LdeQiE
Sunday, June 3, 2018
Sunday, June 03, 2018
MZ Digital Marketing Agency
HEALTH NEWS
No comments
CHICAGO (Reuters) - Patients with advanced multiple myeloma treated with bluebird bio's experimental immunotherapy lived for a median of nearly a year before their cancer worsened, according to data from a small study presented on Friday.

from Reuters: Health News https://ift.tt/2LdeQiE
from Reuters: Health News https://ift.tt/2LdeQiE
Related Posts:
LATEST HEALTH NEWSGlaxoSmithKline received a boost for its oncology research on Thursday, as it reported further positive data from a study of its experimental drug for blood cancer. from Reuters: Health News https://ift.tt/2JrP1iV … Read More
LATEST HEALTH NEWS(Reuters Health) - For firefighters who worked at "Ground Zero" around September 11, 2001, a group of heart-disease risk factors also predicted who was likely to develop World Trade Center-related lung injury years later, res… Read More
LATEST HEALTH NEWSKentucky Attorney General Andy Beshear said on Thursday he had launched an investigation into allegations that pharmacy benefit managers (PBMs) had overcharged state health insurance programs for drugs and discriminated again… Read More
LATEST HEALTH NEWSSwimming is more demanding and burns more calories than a 30-minute land workout from Health https://ift.tt/2TER07m … Read More
LATEST HEALTH NEWSThe average BMI of men in white-collar jobs was 1.17 kg/m2 higher than those in blue-collar occupations from Health https://ift.tt/2T5n93I … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment